Labetalol hydrochloride i.e. Benzamide, 2-hydroxy-5-[l-hydroxy-2-[(l-methyl-3-phenylpropyl)amino]ethyl]-, monohydrochloride (CAS No. 32780-64-6, M.W. 364.87) is an adrenergic P-receptor blocking agent used in the treatment of hypertension, which exhibits both a and P-adrenoceptor blocking activity and because of its use as doping agent in sports, this drug has been added to the list of forbidden substances issued by the International Olympic Committee [1]. The drug is used to induce hypotension during surgery as it decreases blood pressure more rapidly than other beta blockers. The drug is quite sensitive, even a small dose of the drug gives sufficient blockade, thus indicating that the drug is very much confined with the cardio protective effects. Hence, it is must to determine the amount of labetalol hydrochloride in drug formulations. The drug is official in Martindale, The Extra 
INTRODUCTION
364.87) is an adrenergic P-receptor blocking agent used in the treatment of hypertension, which exhibits both a and P-adrenoceptor blocking activity and because of its use as doping agent in sports, this drug has been added to the list of forbidden substances issued by the International Olympic Committee [1] . The drug is used to induce hypotension during surgery as it decreases blood pressure more rapidly than other beta blockers. The drug is quite sensitive, even a small dose of the drug gives sufficient blockade, thus indicating that the drug is very much confined with the cardio protective effects. Hence, it is must to determine the amount of labetalol hydrochloride in drug formulations. The drug is official in Martindale, The Extra Pharmacopoeia [2] . The assay procedure is cited in the monographs of British Pharmacopoeia [3] and United States Pharmacopoeia [4] , which describe a potentiometric titration method and a liquid chromatographic method, respectively.
Several analytical methods such as thin layer chromatography (HPTLC) [5, 6] , high performance liquid chromatography (HPLC) [7, 8] , liquid chromatography (LC) [9, 10] , liquid chromatography coupled with mass spectrometry (LC-MS) [11, 12] , gas chromatography coupled with mass spectrometry (GC-MS) [13] capillary electrophoresis (CE) [14] , electrochemical method [15] and flourimetry [16] are reported for the estimation of labetalol hydrochloride. The determination in biological fluids normally requires the use of trace analysis techniques, higher instrumentation such as HPLC, LC, CE, cyclic voltammetry, flourimetry and hyphenated techniques like LC-MS, GC-MS, inductively coupled plasma-mass spectrometry which normally makes the method much more expensive. In addition to this, these methods require long and tedious pretreatment of the samples and laborious clean up procedures prior to analysis. UV-visible spectrophotometry is the technique of choice even today in the laboratories of research, hospitals and pharmaceutical industries due to its low cost and inherent simplicity. The analytical procedures based on spectrophotometry [17] [18] [19] [20] [21] [22] were frequently published in reputed journals. Few spectrophotometric methods have been developed for the determination of labetalol hydrochloride in bulk drug and pharmaceutical formulations. The quantification of the drug was done based on the reaction of labetalol hydrochloride with Folin Ciocalteau's reagent, 4-aminophenazone, 2,6-dichloroquinone chlorimide and ferric alum [23] ; benzocaine and p-nitroaniline in presence of triethylamine and sodium carbonate, respectively [24] ; p-N, N-dimethylphenylenediamine, and 3-methyl 2-benzothiazolinone hydrazone hydrochloride in the presence of sodium hypochlorite and eerie ammonium sulphate to form intensely coloured products with Xmax at 685 and 545 nm, respectively [25] . The estimation of drug was done in the visible region based on ionpair formation between drug and reagents like suprachen violet 3 B [25] and wool fast blue BL [26] .
This chapter describes a selective and sensitive spectrophotometric method for the determination of labetalol in drug formulations. The method is based on the reaction of 4-aminobenzenesulphonic acid with dilute HCl and NaN02 in a temperature range of 0 -3 °C to form an electrophile i.e positive diazonium ion, which immediately couples at ortho to the hydroxyl group of the benzene ring of labetalol in Na2C03 medium forming a yellow azo product having Xmax at 395 nm.
The proposed method is carefully optimized and validated as per the International Conference on Hormonisation (ICH) guidelines [27] .
EXPERIMENTAL

Apparatus and reagents
The absorbance measurements were made on a Shimadzu UV-visible 1601 spectrophotometer (Kyoto, Tokyo, Japan) with matched quartz cells.
All chemicals and reagents were of analytical grade. Aqueous solutions of 4-aminobenzenesulphonic acid (0.029 M; Fluka Chemie AG, Switzerland), NaN02 (0.29 M; Otto Chemie, Mumbai, India) and sodium carbonate (0.28 M; GR grade, Merck Limited, Mumbai, India) were freshly prepared. A 0.2 M HCl was also prepared by diluting 1.77 ml of pure HCl (35 %, GR grade, Merck Limited, Mumbai, India) in 100 ml, distilled water.
Drug standard and commercial dosage forms
Labetalol hydrochloride as a reference standard was obtained from Sigma Chemical Company (St. Louis, MO, USA). Standard solution of Labetalol hydrochloride (0.04 %) was prepared in distilled water. Commercial dosage forms of labetalol hydrochloride such as Lobet-100 mg tablet (Samarth Pharma Pvt. Ltd., Mumbai, India) and Normadate -50 mg capsule (Glaxo Smithkline, Mumbai, India), were obtained from local drug store.
Spectrophotometric procedure for the determination of labetalol hydrochloride
Into a series of 25 ml standard volumetric flasks, 1.5 ml of 0.029 M 4-aminobenzenesulphonic acid, 1.5 ml of 0.29 M NaNOa and 2.0 ml of 0.2 M HCl were pipetted and kept in an ice-bath (0 -3 °C) for 10.0 min to complete diazotization reaction. To each flask, aliquot of 0.04% labetalol hydrochloride reference standard solution (0.05 -1.1 ml) was added followed by 4.0 ml of 0.28 M sodium carbonate and then diluted to volume with distilled water at room temperature (25 ± 1 °C). The contents of each flask were mixed well and the absorbance was measured at 395 nm against the reagent blank prepared similarly except drug. The colour was stable up to 2 h. The amount of the drug was computed either from the calibration graph or the regression equation.
Procedure for the determination oflabetalol hydrochloride in drug formulations
The powdered contents of 2 capsules of 50 mg strength (or 1 tablet of 100 mg strength) were taken in 50 ml distilled water and left for 10 min for complete dispersion and then filtered through Whatmann No. 42 filter paper (Whatmann International Limited, Kent, UK) in a 250 ml standard volumetric flask. The residue was washed well with distilled water for complete recovery of the drug and then diluted up to the mark with distilled water. The assay was completed following the recommended spectrophotometric procedure for the determination of labetalol hydrochloride
Preparation of degraded labetalol
Labetalol hydrochloride was oxidized by treating 100 mg of the drug in 10 ml distilled water with 0.5 ml saturated sodium carbonate solution and 2.5 ml of 0.3 M sodium metaperiodate for 10 min at room temperature (25 ± 1°C). The excess of sodium carbonate was neutralized with the corresponding volume of HCl and then the products were isolated. The hydrolyzed solution was treated with methyl isobutyl ketone. The two layers were formed and the organic layer was separated out. The extract was then evaporated to dryness at room temperature and the residue as compound 1 (2-hydroxy-5-formylbenzamide) was crystallized from distilled water.
Compound 2 (l-methyl-3-phenylpropylamine), which was in aqueous layer, was extracted with dichloromethane. The extract was evaporated to dryness and the residue was crystallized in ether. Thin layer chromatography was applied using silica gel G plate and a mixture of n -propanol -1% ammonia (4:1, v/v) as mobile phase.
The bands corresponding to labetalol, compound 1 (2-hydroxy-5-formylbenzamide) and compound 2 (l-methyl-3-phenylpropylamine) were located under UV lamp at 254 nm and the Rf values were found to be 0.70, 0.80 and 0.35, respectively. The spots of compound 1 and 2 were too detected by spraying with 2, 4-dinitrophenylhydrazine in 2M HCl and ninhydrin to give yellow and purple spots, respectively, thus indicating the presence of carbonyl group in compound 1 and amine group in compound 2. The literature has confirmed [28] that the two major products of labetalol were 2-hydroxy-5-formylbenzamide (I, compound 1) and l-methyl-3-phenylpropylamine (II, compound 2) (Scheme 3.1) thus confirming the above findings.
Validation
The proposed method has been validated for specificity, linearity, precision, accuracy, and recovery.
Specificity
The sample solutions of labetalol tablet and capsule were subjected to stress conditions of light, heat, acid, base and oxidants. All stressed samples were analyzed for labetalol content and compared to an unstressed time zero reference solution. The reference assay value for the unstressed product was evaluated and the content of degradation in the stressed and control samples was calculated relative to this assay value.
Linearity
The linearity was evaluated by determining labetalol at ten concentration levels: 
Accuracy and precision
Three concentrations within the Hnearity range were selected: 1.6, 8.0, and 16.0 jig ml' for evaluating accuracy and precision. Five independent analyses at each concentration level was performed within one day (intra day assay) and repeated for five consecutive days (inter day assay).
Recovery studies
To study the accuracy of the proposed method and to check the interference from excipients used in the formulations, recovery experiments were carried out by standard addition method. For this, 1.2 ml (or 2.0 ml) of sample solution (0.4 mg ml') was transferred into a 100.0 ml standard volumetric flask followed by 0.8 ml (or 2.0 ml) of reference standard solution (0.4 mg ml'') and volume was completed to the mark with distilled water. The nominal value was determined by the recommended procedure.
RESULTS AND DISCUSSION
Spectral studies
The aqueous solutions of pure labetalol and 4-aminobenzenesulphonic acid concrete absorbance at 395 nm.
Mechanism of the colour reaction
It has been reported that primary aromatic amines such as 4-nitroaniline and 4-aminobenzenesulphonic acid on treatment with HCl and NaN02 in a temperature range of 0-3 °C, yield diazonium salt [29] . However, only strongly nucleophilic electron-rich aromatic or heteroaromatic compounds such as phenol can be coupled with diazonium salts to yield coloured azo compounds [30] . The diazocoupling reaction can be considered as a proton eliminating condensation of a positive diazonium ion with another compound possessing an active hydrogen atom.
The substitution of electrophile usually proceeds para to the active group or ortho if para position is already substituted. In the similar manner, 4-aminobenzenesulphonic acid was diazotized to form a positive diazonium ion. Labetalol is a water-soluble antiadrenergic P-blocker possessing -OH group attached to the benzene ring (phenol) and forms phenolate ion in sodium carbonate medium [31] . The phenolate ion undergoes coupling reaction with positive diazonium ion to form a yellow azo compound, which absorbs maximally at 395 nm. In this case the coupling of diazonium ion proceeds ortho to the hydroxyl group of the benzene ring of labetalol because the para position in the drug is already occupied. The reaction sequence is shown in Scheme 3.2.
Optimization of variables
The different parameters responsible for the formation of diazocoupling coloured product were extensively studied. The optimum conditions for the 
Effect of 4-aminobenzenesulphonic acid concentration
The influence of the concentration of 4-aminobenzenesulphonic acid on the (Fig. 3.2 a) .
Therefore, the concentration of 1.74 x lO' "* M 4-aminobenzenesulphonic acid proved to be sufficient for the maximum concentration of labetalol hydrochloride.
Effect ofNaN02 concentration
The effect of the concentration of NaNOa on the colour development was investigated in the range of 1.16 x 10"^ -2.32 x IQ"^ M. The absorbance (Fig. 3.2 b) increased with increasing concentration of reagent and became constant at 1.16 x 10" M, above which up to 2.32 x 10" M, absorbance remained constant. Therefore 1,74 X 10"^ M; NaNOo was chosen as an optimum value for the determination process.
Effect ofHCl concentration
The 
Effect ofNa2C03 concentration
The effect of the concentration of NaaCOs was studied in the range of 5.60 x 10' -5.04 X 10"2 M. As can be seen from 
Analytical data and calibration graph
The calibration graph between the absorbance at 395 nm and the Iabetalol absorbance and C is the concentration of iabetalol hydrochloride in |j,g ml'' and r = 0.9999, respectively, which indicated an excellent linearity. variance; detection limit and quantitation limit [32] for the proposed method.
The statistical analysis of the calibration data has made possible to calculate error (Sc) in the determination of a given concentration of Iabetalol hydrochloride using the following equation [33] ;
where A and C are average values of the absorbance and concentration, respectively, for n standard samples. The plot of Sc versus concentration of Iabetalol hydrochloride (Fig. 3.3) indicates that the minimum error is obtained when the analysis is carried out at 8.40 jig ml"'. The value of Sc can be used to establish the confidence limit at the selected level of significance for the determination of unknown concentrations of Iabetalol hydrochloride using the relation Cj ± tSc. The resuhs are presented graphically (Fig. 3.4) by plotting the relative uncertainty (%AC/C) against the concentration of Iabetalol hydrochloride [34] at 95 and 99 % confidence levels for n-2 degrees of freedom. Thus, the confidence limit can be established and the relative uncertainty can be estimated directly on the concentration over the full range of the concentration tested.
Specificity
The specificity of the proposed method was evaluated by estimating the amount of Iabetalol in the presence of varying amounts of degraded products of Stability (h) Beer's law limit (}j,g ml"') Molar absorptivity (1 mol"' cm"') Linear regression equation labetalol such as 2-hydroxy-5-formylbenzamide and l-methyl-3-phenylpropylamine, which were the major degradants of labetalol. It was found that l-methyl-3-phenylpropylamine did not interfere with the proposed method whereas 2-hydroxy-5-formylbezamide interferes seriously.
The various excipients commonly used in dosage forms such as sodium stearyl fumarate, magnesium stearate, starch, lactose and talc did not interfere with the proposed method. The samples were stressed by light, acid and base for 2, 2 and 5-day-time points, respectively at room temperature (25 ± 1°C). It was observed that stress by such conditions did not cause significant degradation. There was no change in the absorption spectra of the pure drug and stressed (light, acid and base) sample solutions. The two reported metabolites of labetalol such as 0-sulphate (I, major) and 0-glucuronide (11, minor) (Scheme 3.3) were not interfering with the proposed method because of denature of the phenolic group in these metabolites [35] . The proposed method is specific and selective as not giving reaction with compounds, which lack phenol group in the moiety.
Robustness
The robustness of the proposed method relative to each operational parameter was challenged. The operational parameters investigated were as follows:
• volume of 0.029 M 4-aminobenzenesulphonic acid, 1.5 ml (± 0.5 ml)
• volume of 0.29 M NaN02, 1.5 ml (± 0.5 ml)
• volume of 0.2 M HCl, 2.0 ml (± 0.5 ml)
• volume of 0.28 M Na2C03,4.0 ml (± 1.0 ml)
• cooling time of 10 min (± 3.0 min)
Under these conditions quality control sample solution containing 8.0 fig   ml" (Lobet 100, Samarth Pharma) of labetalol hydrochloride was assayed five times. The results obtained by the quality control sample represent good recovery with acceptable bias of OL >0.98 and BU < 1.02.
Ruggedness
The method ruggedness was evaluated by a second analyst using a different 
Accuracy and precision of the proposed methods
The accuracy and precision of the proposed method was established by determining the content of labetalol in pure and pharmaceutical formulations at three different concentration levels (1.6, 8.0, and 16.0 j^g ml''). The intra day and inter day precisions of the proposed method in pure form was evaluated by carrying out five independent analyses at each concentration level within one day and on five consecutive days (Table 3 ,2). In the same manner, the intra and inter day precisions was also performed in drug formulations by measuring the amount of labetalol at each concentration level (Table 3. 3). The results presented in Table 3 .2 and 3.3 can be considered to be very satisfactory. Mean for five independent analyses. '' SAE, standard analytical error. '^ C.L., confidence limit at 95% confidence level and four degrees of freedom (t = 2.776). The validity of the proposed method was evaluated by recovery studies using the standard addition method. For this purpose, a known amount of reference drug was added to formulated tablets and capsules at two different concentration levels and the nominal amount of drug was determined by the proposed method. Each concentration level was analyzed five times and the results (Table 3. The applicability of the proposed method has been tested for the determination of labetalol in drug formulations. The results of the proposed method were compared with those obtained by the Bilal's spectrophotometic method [24] using point and interval hypothesis tests [36] . The student's t and F-values at 95% confidence level did not exceed the tabulated t-and F-values, confirming no significant difference between the performance of the proposed method and the reference method (Table   3 .5). Once it is ensured that the proposed method is not significantly different from the reference method, it is necessary to check the bias of each drug sample based on recovery experiments using the interval hypothesis test. In pharmaceutical analysis,
The Canadian Health Protection Branch has recommended a bias of ± 2 % with lower limit (BL) of 0.98 and upper limit (0u) of 1.02 [37] . It is evident from Table 3.5 that the true bias of all samples is < ± 2 %. The interval hypothesis test has confirmed that the accuracy and precision are within the acceptable limits and indicated no significant difference between the performances of the proposed method and the reference method at 95% confidence level.
The proposed method for the determination of labetalol hydrochloride in drug formulations was compared favourably with other existing spectrophotometric methods (Table 3 .6). The molar absorptivity of the proposed method is higher than that of other methods indicating its greater sensitivity. It has the advantage of determining labetalol as low as 0.8 |.ig ml"'. Moreover, the proposed method is fast with respect to analysis time and directly applicable to the drug sample without prior extraction needed in other methods [25, 26] . The method is versatile and useful due to independence from pH and high tolerance limit from common excipients present in drug formulations.
